SEC Form 4 · accession 0001079974-18-000240
InventaBioTech Inc. · INVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
BOCO Investments LLC
10% Owner
Period of report
Feb 26, 2018
Accepted (ET)
May 1, 2018 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001421603
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2018 | J | 200,944 | $0.75 | A | 8,706,596 | D | |
| Common Stock | Feb 26, 2018 | P | 801,438 | $0.75 | A | 9,508,034 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $0.95 | Feb 26, 2018 | P | 1,002,382 | A | Feb 26, 2018 | Feb 26, 2021 | Common | 1,002,382 | 1,002,382 | D |
Explanation of responses
- F1The common stock received represents the conversion of a Secured Convertible Promissory Note in the principal amount of $148,920.94 at a per share price of $0.75.